Sign In
Buy MDT
$85.39
-0.320 (-0.373%)
At Close: Jul 31, 2026
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
10:31am, Thursday, 23'rd May 2024
While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare
Medtronic Q4 earnings: ‘we're optimistic about fiscal 2025'
09:23am, Thursday, 23'rd May 2024
Medtronic PLC (NYSE: MDT) is in focus on Thursday after reporting market-beating financial results for its fourth quarter. Medtronic issues in-line guidance The stock is flat at writing because $MDT
Medtronic (MDT) Q4 Earnings and Revenues Surpass Estimates
08:56am, Thursday, 23'rd May 2024
Medtronic (MDT) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.57 per share a year ago.
Medtronic's stock rises after earnings beat expectations and the dividend was raised
07:02am, Thursday, 23'rd May 2024
Shares of Medtronic PLC MDT, +0.69% rallied 1.3% in premarket trading Thursday, after the medical device and therapies company reported fiscal fourth-quarter profit and revenue that rose above expecta
Medtronic beats quarterly profit estimates on medical devices strength
06:52am, Thursday, 23'rd May 2024
Health tech firm Medtronic beat Wall Street estimates for quarterly profit on Thursday, aided by a post-pandemic pickup in surgical volumes at hospitals that boosted demand for its medical devices.
Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase
06:45am, Thursday, 23'rd May 2024
Broad-based, durable growth across the company, including Cranial & Spinal Technologies, Diabetes, Cardiac Pacing, Surgical, and Structural Heart; gaining momentum as company enters new product cycles
7 Blue-Chip Stocks to Buy Now: May 2024
06:00am, Thursday, 23'rd May 2024
If the market's dramatic shifts this year have left you feeling unsettled, you're not alone. Despite widespread overvaluation in many tech stocks, plenty of blue-chip stocks to buy can provide the por
Medtronic's (MDT) MiniMed 780G AID System Wins New Accolade
10:11am, Wednesday, 22'nd May 2024
Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.
3 Healthcare Stocks to Buy Now: May 2024
03:04pm, Tuesday, 21'st May 2024
It's a great time to be looking at healthcare stocks to buy now. According to research from BlackRock, U.S. healthcare stocks have outperformed the overall stock market by an average of 10% over the p
Will Medtronic Stock See Higher Levels Post Q4 Results After 5% Gains This Year?
08:45am, Tuesday, 21'st May 2024
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2024 fourth-quarter results on Thursday, May 23 (fiscal ends in April). We expect Medtronic Medtronic stock to trade sideways post-Q4 results an
Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome
11:01am, Monday, 20'th May 2024
Medtronic's (MDT) Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy for the treatment of AFib.
Unlocking Q4 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics
10:16am, Monday, 20'th May 2024
Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for som
Karmanos Welcomes Wasif Saif, M.D., to Lead Phase 1 Clinical Trials
06:15am, Monday, 20'th May 2024
Internationally known clinical and translational researcher also co-leads the GI oncology team DETROIT, May 20, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D.
Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome
12:00am, Monday, 20'th May 2024
Medtronic plc (MDT Quick QuoteMDT - Free Report) recently announced positive results demonstrating the safety and efficacy of the Affera Mapping and Ablation System with the Sphere-9 Catheter. The SPH
HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life DUBLIN and BOSTON, May 17, 2024
